HTSUY (Hisamitsu Pharmaceutical Co) E10: $0.36 (As of Nov. 2025)


HTSUY Hisamitsu Pharmaceutical Co Inc HTSUY
87 GF Score
Price $2.94
GF Value $2.39
Valuation Modestly Overvalued
View Full Analysis

What is Hisamitsu Pharmaceutical Co E10?

Hisamitsu Pharmaceutical Co HTSUY 87 E10 is $0.36 as of Nov. 2025. GuruFocus rates HTSUY with a GF Score™ of 87/100 and a GF Value™ of $2.39 (Modestly Overvalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hisamitsu Pharmaceutical Co's adjusted earnings per share data for the three months ended in Nov. 2025 was $0.111. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.36 for the trailing ten years ended in Nov. 2025.

During the past 12 months, Hisamitsu Pharmaceutical Co's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Hisamitsu Pharmaceutical Co was 1.00% per year. The lowest was -3.90% per year. And the median was -2.40% per year.

As of today (2026-06-29), Hisamitsu Pharmaceutical Co's current stock price is $2.94. Hisamitsu Pharmaceutical Co's E10 for the quarter that ended in Nov. 2025 was $0.36. Hisamitsu Pharmaceutical Co's Shiller PE Ratio of today is 8.17.

During the past 13 years, the highest Shiller PE Ratio of Hisamitsu Pharmaceutical Co was 37.52. The lowest was 17.68. And the median was 22.68.


Hisamitsu Pharmaceutical Co  (OTCPK:HTSUY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hisamitsu Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2.94/0.36
=8.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Hisamitsu Pharmaceutical Co was 37.52. The lowest was 17.68. And the median was 22.68.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hisamitsu Pharmaceutical Co E10 Related Terms


Hisamitsu Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Hisamitsu Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co E10 Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.31 0.38 0.35 0.00

Hisamitsu Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.35 0.37 0.36 0.00

HTSUY vs ESPR, AMPH, ETON: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Shiller PE Ratio falls into.


HTSUY
87GF Score
Hisamitsu Pharmaceutical Co Inc HTSUY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hisamitsu Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hisamitsu Pharmaceutical Co's adjusted earnings per share data for the three months ended in Nov. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Nov. 2025 (Change)*Current CPI (Nov. 2025)
=0.111/113.2000*113.2000
=0.111

Current CPI (Nov. 2025) = 113.2000.

Hisamitsu Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201602 0.064 97.800 0.074
201605 0.123 98.200 0.142
201608 0.138 97.900 0.160
201611 0.246 98.600 0.282
201702 0.055 98.100 0.063
201705 0.098 98.600 0.113
201708 0.155 98.500 0.178
201711 0.171 99.100 0.195
201802 0.091 99.500 0.104
201805 0.094 99.300 0.107
201808 0.153 99.800 0.174
201811 0.110 100.000 0.125
201902 0.160 99.700 0.182
201905 0.053 100.000 0.060
201908 0.160 100.000 0.181
201911 0.220 100.500 0.248
202002 0.091 100.300 0.103
202005 0.003 100.100 0.003
202008 0.103 100.100 0.116
202011 0.059 99.500 0.067
202102 0.102 99.800 0.116
202105 0.066 99.400 0.075
202108 0.073 99.700 0.083
202111 0.033 100.100 0.037
202202 0.093 100.700 0.105
202205 0.040 101.800 0.044
202208 0.113 102.700 0.125
202211 0.066 103.900 0.072
202302 0.054 104.000 0.059
202305 0.095 105.100 0.102
202308 0.097 105.900 0.104
202311 0.081 106.900 0.086
202402 0.042 106.900 0.044
202405 0.102 108.100 0.107
202408 0.100 109.100 0.104
202411 0.101 110.000 0.104
202502 0.182 110.800 0.186
202505 0.061 111.800 0.062
202508 0.105 112.100 0.106
202511 0.111 113.200 0.111

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.36 mean?
Hisamitsu Pharmaceutical Co (HTSUY) has a E10 of $0.36 as of Nov. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hisamitsu Pharmaceutical Co and its competitors.
Is Hisamitsu Pharmaceutical Co's E10 too high?
Hisamitsu Pharmaceutical Co's current E10 is $0.36. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's E10 compare to ESPR and AMPH?
Hisamitsu Pharmaceutical Co's E10 of $0.36 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hisamitsu Pharmaceutical Co and its competitors. Hisamitsu Pharmaceutical Co's current E10 is $0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co (HTSUY) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.39, compared to a current price of $2.94 — trading 23% above its estimated fair value. The current E10 is $0.36. Hisamitsu Pharmaceutical Co's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (HTSUY), the current E10 is $0.36 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hisamitsu Pharmaceutical Co (HTSUY) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of $2.94 is trading 23% above its estimated GF Value™ of $2.39. GuruFocus considers Hisamitsu Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for HTSUY:

  • E10: $0.36
  • GF Value™: $2.39 vs. price of $2.94 (23% above fair value)
  • GF Score™: 87/100

No single metric tells the full story. See the HTSUY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hisamitsu Pharmaceutical Co Business Description

Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
87GF Score

Get the complete analysis for HTSUY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.94
Price
$2.39
GF Value